Venture Life Group PLC (VLG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Venture Life Group PLC (VLG) has a cash flow conversion efficiency ratio of 0.009x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX691.00K ≈ $84.07 USD) by net assets (GBX75.23 Million ≈ $9.15K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Venture Life Group PLC - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Venture Life Group PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Venture Life Group PLC debt and liabilities for a breakdown of total debt and financial obligations.
Venture Life Group PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Venture Life Group PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MAPSPEOPLE A/S DK-02
F:70R
|
N/A |
|
Braemar Plc
LSE:BMS
|
0.012x |
|
Carr's Group plc
LSE:CARR
|
0.075x |
|
Founder Group Limited Ordinary Shares
NASDAQ:FGL
|
-0.585x |
|
Maven Income And Growth Vct Plc
LSE:MIG1
|
-0.003x |
|
Aloro Mining Corp
V:AORO
|
-0.003x |
|
Premier Health of America Inc
V:PHA
|
-0.621x |
|
IMAGE POWER S.A. ZY -10
F:7UQ
|
0.628x |
Annual Cash Flow Conversion Efficiency for Venture Life Group PLC (2010–2024)
The table below shows the annual cash flow conversion efficiency of Venture Life Group PLC from 2010 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Venture Life Group PLC worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX75.41 Million ≈ $9.18K |
GBX8.35 Million ≈ $1.02K |
0.111x | +2.73% |
| 2023-12-31 | GBX76.25 Million ≈ $9.28K |
GBX8.22 Million ≈ $1.00K |
0.108x | +46.53% |
| 2022-12-31 | GBX75.66 Million ≈ $9.21K |
GBX5.57 Million ≈ $677.22 |
0.074x | +795.58% |
| 2021-12-31 | GBX73.16 Million ≈ $8.90K |
GBX601.00K ≈ $73.12 |
0.008x | -78.11% |
| 2020-12-31 | GBX72.11 Million ≈ $8.77K |
GBX2.71 Million ≈ $329.24 |
0.038x | -49.55% |
| 2019-12-31 | GBX32.82 Million ≈ $3.99K |
GBX2.44 Million ≈ $297.00 |
0.074x | +902.63% |
| 2018-12-31 | GBX32.08 Million ≈ $3.90K |
GBX238.00K ≈ $28.96 |
0.007x | +225.28% |
| 2017-12-31 | GBX14.19 Million ≈ $1.73K |
GBX-84.00K ≈ $-10.22 |
-0.006x | +81.40% |
| 2016-12-31 | GBX14.36 Million ≈ $1.75K |
GBX-457.00K ≈ $-55.60 |
-0.032x | +60.39% |
| 2015-12-31 | GBX13.80 Million ≈ $1.68K |
GBX-1.11 Million ≈ $-134.93 |
-0.080x | +43.47% |
| 2014-12-31 | GBX15.65 Million ≈ $1.90K |
GBX-2.22 Million ≈ $-270.60 |
-0.142x | +92.35% |
| 2013-12-31 | GBX557.00K ≈ $67.77 |
GBX-1.03 Million ≈ $-125.93 |
-1.858x | +54.27% |
| 2012-12-31 | GBX127.00K ≈ $15.45 |
GBX-516.00K ≈ $-62.78 |
-4.063x | -164.65% |
| 2011-12-31 | GBX312.00K ≈ $37.96 |
GBX-479.00K ≈ $-58.28 |
-1.535x | -30.19% |
| 2010-12-31 | GBX212.00K ≈ $25.79 |
GBX-250.00K ≈ $-30.42 |
-1.179x | -- |
About Venture Life Group PLC
Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermat… Read more